Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Correlating CFTR Function with Clinical Features to Inform Precision Treatment of Cystic Fibrosis.

McCague AF, Raraigh KS, Pellicore MJ, Davis-Marcisak EF, Evans TA, Han ST, Lu Z, Joynt AT, Sharma N, Castellani C, Collaco JM, Corey M, Lewis MH, Penland CM, Rommens JM, Stephenson AL, Sosnay PR, Cutting GR.

Am J Respir Crit Care Med. 2019 Mar 19. doi: 10.1164/rccm.201901-0145OC. [Epub ahead of print]

PMID:
30888834
2.

Reply: Predictors of Reduced Survival for Adult-diagnosed Cystic Fibrosis: Older Age at Diagnosis, a Substitute for Older Age?

Desai S, Wong H, Sykes J, Stephenson AL, Singer J, Quon BS.

Ann Am Thorac Soc. 2019 Jan 30. doi: 10.1513/AnnalsATS.201901-063LE. [Epub ahead of print] No abstract available.

PMID:
30698985
3.

Cluster and CART analyses identify large subgroups of adults with cystic fibrosis at low risk of 10-year death.

Burgel PR, Lemonnier L, Dehillotte C, Sykes J, Stanojevic S, Stephenson AL, Paillasseur JL.

Eur Respir J. 2019 Mar 14;53(3). pii: 1801943. doi: 10.1183/13993003.01943-2018. Print 2019 Mar.

PMID:
30578399
4.

Pre-transplant factors associated with mortality after lung transplantation in cystic fibrosis: A systematic review and meta-analysis.

Koutsokera A, Varughese RA, Sykes J, Orchanian-Cheff A, Shah PS, Chaparro C, Tullis E, Singer LG, Stephenson AL.

J Cyst Fibros. 2018 Oct 25. pii: S1569-1993(18)30899-3. doi: 10.1016/j.jcf.2018.10.013. [Epub ahead of print]

PMID:
30482682
5.

Validation of the French 3-year prognostic score using the Canadian Cystic Fibrosis registry.

Coriati A, Sykes J, Nkam L, Hocine MN, Burgel PR, Stephenson AL.

J Cyst Fibros. 2018 Nov 2. pii: S1569-1993(18)30911-1. doi: 10.1016/j.jcf.2018.10.014. [Epub ahead of print]

PMID:
30396836
6.

Cystic fibrosis survival: the changing epidemiology.

Corriveau S, Sykes J, Stephenson AL.

Curr Opin Pulm Med. 2018 Nov;24(6):574-578. doi: 10.1097/MCP.0000000000000520.

PMID:
30281026
7.

Functional Tests of Leg Muscle Strength and Power in Adults With Cystic Fibrosis.

Sheppard E, Chang K, Cotton J, Gashgarian S, Slack D, Wu K, Michalski A, Fox P, Stephenson AL, Mathur S.

Respir Care. 2019 Jan;64(1):40-47. doi: 10.4187/respcare.06224. Epub 2018 Sep 25.

PMID:
30254046
8.

Recent advances in developing therapeutics for cystic fibrosis.

Strug LJ, Stephenson AL, Panjwani N, Harris A.

Hum Mol Genet. 2018 Aug 1;27(R2):R173-R186. doi: 10.1093/hmg/ddy188.

PMID:
30060192
9.

Finding meaningful work in difficult circumstances: A study of prison healthcare workers.

Stephenson AL, Bell N.

Health Serv Manage Res. 2018 Jan 1:951484818787698. doi: 10.1177/0951484818787698. [Epub ahead of print]

PMID:
29999425
10.

Serotonergic antidepressant use and morbidity and mortality among older adults with COPD.

Vozoris NT, Wang X, Austin PC, Stephenson AL, O'Donnell DE, Gershon AS, Gill SS, Rochon PA.

Eur Respir J. 2018 Jul 27;52(1). pii: 1800475. doi: 10.1183/13993003.00475-2018. Print 2018 Jul.

PMID:
29946006
11.

Clinical Characteristics and Predictors of Reduced Survival for Adult-diagnosed Cystic Fibrosis. Analysis of the Canadian CF Registry.

Desai S, Wong H, Sykes J, Stephenson AL, Singer J, Quon BS.

Ann Am Thorac Soc. 2018 Oct;15(10):1177-1185. doi: 10.1513/AnnalsATS.201801-037OC.

PMID:
29944384
12.

The impact of National Cystic Fibrosis Registries: A review series.

Stephenson AL, Bilton D.

J Cyst Fibros. 2018 May;17(3):287-288. doi: 10.1016/j.jcf.2018.04.001. Epub 2018 Apr 21. No abstract available.

PMID:
29685814
13.

Prevalence of hypoglycemia during oral glucose tolerance testing in adults with cystic fibrosis and risk of developing cystic fibrosis-related diabetes.

Mannik LA, Chang KA, Annoh PQK, Sykes J, Gilmour J, Robert R, Stephenson AL.

J Cyst Fibros. 2018 Jul;17(4):536-541. doi: 10.1016/j.jcf.2018.03.009. Epub 2018 Apr 19.

PMID:
29680365
14.

Reference percentiles of FEV1 for the Canadian cystic fibrosis population: comparisons across time and countries.

Kim SO, Corey M, Stephenson AL, Strug LJ.

Thorax. 2018 May;73(5):446-450. doi: 10.1136/thoraxjnl-2017-210899. Epub 2018 Feb 6.

PMID:
29434047
15.

Clinical characteristics of cystic fibrosis patients prior to lung transplantation: An international comparison between Canada and the United States.

Quon BS, Sykes J, Stanojevic S, Marshall BC, Petren K, Ostrenga J, Fink A, Elbert A, Faro A, Goss CH, Stephenson AL.

Clin Transplant. 2018 Mar;32(3):e13188. doi: 10.1111/ctr.13188. Epub 2018 Feb 11.

16.

Comparison of Nutrition and Lung Function Outcomes in Patients with Cystic Fibrosis Living in Canada and the United States.

Goss CH, Sykes J, Stanojevic S, Marshall B, Petren K, Ostrenga J, Fink A, Elbert A, Quon BS, Stephenson AL.

Am J Respir Crit Care Med. 2018 Mar 15;197(6):768-775. doi: 10.1164/rccm.201707-1541OC.

17.

Voice of the Clinician: the case of an Australian health system.

Lock MJ, Stephenson AL, Branford J, Roche J, Edwards MS, Ryan K.

J Health Organ Manag. 2017 Sep 18;31(6):665-678. doi: 10.1108/JHOM-05-2017-0113.

18.

Social identity and the prison health worker: Implications for practitioner satisfaction and turnover intentions.

Stephenson AL, Bell N.

Health Care Manage Rev. 2017 Aug 23. doi: 10.1097/HMR.0000000000000179. [Epub ahead of print]

PMID:
28837501
19.

Adverse cardiac events associated with incident opioid drug use among older adults with COPD.

Vozoris NT, Wang X, Austin PC, Lee DS, Stephenson AL, O'Donnell DE, Gill SS, Rochon PA.

Eur J Clin Pharmacol. 2017 Oct;73(10):1287-1295. doi: 10.1007/s00228-017-2278-3. Epub 2017 Jun 29.

PMID:
28664359
20.

Don't judge a book by its cover: the emerging challenge of diagnosing CF in non-Caucasians.

Chin M, Strug L, Stephenson AL.

J Cyst Fibros. 2017 Jul;16(4):439-440. doi: 10.1016/j.jcf.2017.05.007. Epub 2017 Jun 7. No abstract available.

PMID:
28599956
21.

The changing epidemiology and demography of cystic fibrosis.

Stephenson AL, Stanojevic S, Sykes J, Burgel PR.

Presse Med. 2017 Jun;46(6 Pt 2):e87-e95. doi: 10.1016/j.lpm.2017.04.012. Epub 2017 May 26.

PMID:
28554720
22.

Clinical Outcomes Associated with Achromobacter Species Infection in Patients with Cystic Fibrosis.

Somayaji R, Stanojevic S, Tullis DE, Stephenson AL, Ratjen F, Waters V.

Ann Am Thorac Soc. 2017 Sep;14(9):1412-1418. doi: 10.1513/AnnalsATS.201701-071OC.

PMID:
28406714
23.

Survival Comparison of Patients With Cystic Fibrosis in Canada and the United States: A Population-Based Cohort Study.

Stephenson AL, Sykes J, Stanojevic S, Quon BS, Marshall BC, Petren K, Ostrenga J, Fink AK, Elbert A, Goss CH.

Ann Intern Med. 2017 Apr 18;166(8):537-546. doi: 10.7326/M16-0858. Epub 2017 Mar 14.

24.

A clinical tool to calculate post-transplant survival using pre-transplant clinical characteristics in adults with cystic fibrosis.

Stephenson AL, Sykes J, Berthiaume Y, Singer LG, Chaparro C, Aaron SD, Whitmore GA, Stanojevic S.

Clin Transplant. 2017 Jun;31(6). doi: 10.1111/ctr.12950. Epub 2017 Apr 23.

PMID:
28267234
25.

Inhaled Long-acting Anticholinergics and Urinary Tract Infection in Individuals with COPD.

Gershon AS, Newman AM, Fischer HD, Austin PC, Daneman N, Bell CM, Stephenson AL, Gill SS, Vozoris NT, Rochon PA.

COPD. 2017 Feb;14(1):105-112. doi: 10.1080/15412555.2016.1202912. Epub 2016 Oct 12.

PMID:
27732117
26.

Journey Toward Evidence-Based Status: Seeking Admission to Formal Program Registries.

Stephenson AL.

Health Promot Pract. 2017 Sep;18(5):681-687. doi: 10.1177/1524839916670575. Epub 2016 Sep 19.

PMID:
27647322
27.

Incident opioid drug use and adverse respiratory outcomes among older adults with COPD.

Vozoris NT, Wang X, Fischer HD, Bell CM, O'Donnell DE, Austin PC, Stephenson AL, Gill SS, Rochon PA.

Eur Respir J. 2016 Sep;48(3):683-93. doi: 10.1183/13993003.01967-2015. Epub 2016 Jul 13.

28.

The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry.

Stephenson AL, Bell SC.

Ann Am Thorac Soc. 2016 Jul;13(7):1014-5. doi: 10.1513/AnnalsATS.201604-250ED. No abstract available.

PMID:
27388403
29.

The benefits of newborn screening for cystic fibrosis: The Canadian experience.

Mak DY, Sykes J, Stephenson AL, Lands LC.

J Cyst Fibros. 2016 May;15(3):302-8. doi: 10.1016/j.jcf.2016.04.001. Epub 2016 Apr 21.

30.

Health Care Use During Transfer to Adult Care Among Youth With Chronic Conditions.

Cohen E, Gandhi S, Toulany A, Moore C, Fu L, Orkin J, Levy D, Stephenson AL, Guttmann A.

Pediatrics. 2016 Mar;137(3):e20152734. doi: 10.1542/peds.2015-2734. Epub 2016 Feb 23.

31.

A standardized approach to estimating survival statistics for population-based cystic fibrosis registry cohorts.

Sykes J, Stanojevic S, Goss CH, Quon BS, Marshall BC, Petren K, Ostrenga J, Fink A, Elbert A, Stephenson AL.

J Clin Epidemiol. 2016 Feb;70:206-13. doi: 10.1016/j.jclinepi.2015.08.026. Epub 2015 Oct 3.

32.

Incident opioid drug use among older adults with chronic obstructive pulmonary disease: a population-based cohort study.

Vozoris NT, Wang X, Fischer HD, Gershon AS, Bell CM, Gill SS, O'Donnell DE, Austin PC, Stephenson AL, Rochon PA.

Br J Clin Pharmacol. 2016 Jan;81(1):161-70. doi: 10.1111/bcp.12762. Epub 2015 Oct 2.

33.

Clinical and demographic factors associated with post-lung transplantation survival in individuals with cystic fibrosis.

Stephenson AL, Sykes J, Berthiaume Y, Singer LG, Aaron SD, Whitmore GA, Stanojevic S.

J Heart Lung Transplant. 2015 Sep;34(9):1139-45. doi: 10.1016/j.healun.2015.05.003. Epub 2015 May 7.

PMID:
26087666
34.

A statistical model to predict one-year risk of death in patients with cystic fibrosis.

Aaron SD, Stephenson AL, Cameron DW, Whitmore GA.

J Clin Epidemiol. 2015 Nov;68(11):1336-45. doi: 10.1016/j.jclinepi.2014.12.010. Epub 2014 Dec 31.

PMID:
25655532
35.

Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD.

Vozoris NT, Stephenson AL.

Eur Respir J. 2015 Feb;45(2):566-7. doi: 10.1183/09031936.00172714. No abstract available.

36.

A contemporary survival analysis of individuals with cystic fibrosis: a cohort study.

Stephenson AL, Tom M, Berthiaume Y, Singer LG, Aaron SD, Whitmore GA, Stanojevic S.

Eur Respir J. 2015 Mar;45(3):670-9. doi: 10.1183/09031936.00119714. Epub 2014 Nov 13.

37.

Cystic fibrosis (cf) and ovarian reserve: A cross-sectional study examining serum anti-mullerian hormone (amh) in young women.

Schram CA, Stephenson AL, Hannam TG, Tullis E.

J Cyst Fibros. 2015 May;14(3):398-402. doi: 10.1016/j.jcf.2014.09.008. Epub 2014 Oct 1.

38.

Current use of domperidone and co-prescribing of medications that increase its arrhythmogenic potential among older adults: a population-based cohort study in Ontario, Canada.

Rojas-Fernandez C, Stephenson AL, Fischer HD, Wang X, Mestre T, Hutson JR, Pondal M, Lee DS, Rochon PA, Marras C.

Drugs Aging. 2014 Nov;31(11):805-13. doi: 10.1007/s40266-014-0215-z.

PMID:
25227452
39.

Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.

Gershon AS, Campitelli MA, Croxford R, Stanbrook MB, To T, Upshur R, Stephenson AL, Stukel TA.

JAMA. 2014 Sep 17;312(11):1114-21. doi: 10.1001/jama.2014.11432.

PMID:
25226477
40.

Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD.

Vozoris NT, Fischer HD, Wang X, Stephenson AL, Gershon AS, Gruneir A, Austin PC, Anderson GM, Bell CM, Gill SS, Rochon PA.

Eur Respir J. 2014 Aug;44(2):332-40. doi: 10.1183/09031936.00008014. Epub 2014 Apr 17.

41.

Demographic characteristics and healthcare use of centenarians: a population-based cohort study.

Rochon PA, Gruneir A, Wu W, Gill SS, Bronskill SE, Seitz DP, Bell CM, Fischer HD, Stephenson AL, Wang X, Gershon AS, Anderson GM.

J Am Geriatr Soc. 2014 Jan;62(1):86-93. doi: 10.1111/jgs.12613. Epub 2014 Jan 2.

PMID:
24383610
42.

Abdominal pain in adults with cystic fibrosis.

Nash EF, Ohri CM, Stephenson AL, Durie PR.

Eur J Gastroenterol Hepatol. 2014 Feb;26(2):129-36. doi: 10.1097/MEG.0000000000000011. Review.

PMID:
24366450
43.

The effect of patient care order sets on medical resident education: a prospective before-after study.

Yu CH, Stephenson AL, Gupta S.

BMC Med Educ. 2013 Nov 6;13:146. doi: 10.1186/1472-6920-13-146.

44.

Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities.

Li W, Soave D, Miller MR, Keenan K, Lin F, Gong J, Chiang T, Stephenson AL, Durie P, Rommens J, Sun L, Strug LJ.

Hum Genet. 2014 Feb;133(2):151-61. doi: 10.1007/s00439-013-1363-7. Epub 2013 Sep 22.

PMID:
24057835
45.

Tendon Injury and Fluoroquinolone Use: A Systematic Review.

Stephenson AL, Wu W, Cortes D, Rochon PA.

Drug Saf. 2013 Sep;36(9):709-21. doi: 10.1007/s40264-013-0089-8. Review.

PMID:
23888427
46.

Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: a population-based cohort study.

Stephenson AL, Mannik LA, Walsh S, Brotherwood M, Robert R, Darling PB, Nisenbaum R, Moerman J, Stanojevic S.

Am J Clin Nutr. 2013 Apr;97(4):872-7. doi: 10.3945/ajcn.112.051409. Epub 2013 Feb 6.

PMID:
23388659
47.

Benzodiazepine use among older adults with chronic obstructive pulmonary disease: a population-based cohort study.

Vozoris NT, Fischer HD, Wang X, Anderson GM, Bell CM, Gershon AS, Stephenson AL, Gill SS, Rochon PA.

Drugs Aging. 2013 Mar;30(3):183-92. doi: 10.1007/s40266-013-0056-1.

PMID:
23371396
48.

Quantitative tracking of the growth of individual algal cells in microdroplet compartments.

Pan J, Stephenson AL, Kazamia E, Huck WT, Dennis JS, Smith AG, Abell C.

Integr Biol (Camb). 2011 Oct;3(10):1043-51. doi: 10.1039/c1ib00033k. Epub 2011 Aug 24.

PMID:
21863189
49.

The environmental and economic sustainability of potential bioethanol from willow in the UK.

Stephenson AL, Dupree P, Scott SA, Dennis JS.

Bioresour Technol. 2010 Dec;101(24):9612-23. doi: 10.1016/j.biortech.2010.07.104. Epub 2010 Jul 29.

PMID:
20727740
50.

Impaired exercise performance after successful liver transplantation.

Stephenson AL, Yoshida EM, Abboud RT, Fradet G, Levy RD.

Transplantation. 2001 Sep 27;72(6):1161-4.

PMID:
11579319

Supplemental Content

Loading ...
Support Center